ScreenerHero
AELISAelis Farma SA
EPA · FR · Healthcare · Biotechnology · aelisfarma.com
1.030EUR-2.83%Mkt Cap: 15.71M $P/E: —

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company owns a pipeline of pharmacolo…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap15.71M $
Enterprise Value13.65M $
Revenue (TTM)2.27M $
Gross Profit2.27M $
Net Income (TTM)-6.99M $
Revenue/Share0.1652 USD
Last Price1.030 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees16
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0014007ZB4
Valuation
P/E (Trailing)—
P/E (Forward)6.34
PEG—
EV/EBITDA-2.06
EV/Revenue6.02
P/S7.05
P/B3.31
EPS (TTM)-0.47
EPS (Forward)0.17
52W Range
0.95006% of range2.300
52W High2.300 EUR
52W Low0.9500 EUR
Profitability
Gross Margin100.00%
Oper. Margin-172.75%
EBITDA Margin-293.14%
Profit Margin0.00%
ROE-144.94%
ROA-53.40%
Growth
Revenue Growth-17.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.82M $
CapEx (TTM)4.35K $
FCF Margin-148.83%
FCF Yield-21.46%
Net Debt-2.29M $
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity1.49
Current Ratio4.40
Quick Ratio4.13
Book Value/Sh0.3260 EUR
Cash/Share0.6400 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.63M
Float3.89M
Insiders36.44%
Institutions27.52%
Technical
SMA 501.042 (-1.1%)
SMA 2001.200 (-14.1%)
Beta0.62
S&P 52W Chg18.16%
Avg Vol (30d)17.08K
Avg Vol (10d)22.49K
Technical Indicators
RSI (14)51.1
MACD0.0060
MACD Signal-0.0016
MACD Hist.+0.0076
BB Upper1.100 EUR
BB Middle1.041 EUR
BB Lower0.9815 EUR
BB Width11.42%
ATR (14)0.0507 EUR
Vol Ratio (20d)1.74x